PGY-6 Riccardo Serra performing a STA-MCA bypass for Moya-Moya disease with Dr. Jacob Cherian. Complex vascular pathology is a central part of our chief residents training.

"Middle Meningeal Artery Embolization for Nonacute Subdural Hematoma: A Meta-Analysis of Large Randomized Controlled Trials" https://t.co/cDh3wjOESM @HAlvinChenNeuro; @marcocolasurdo

Extraordinary work by our PD @DrPJKaras for bringing our resident complement to 2 a year. Game changer for our residents’ education and research experience @UTMBProvost @UTMBPresident

New manuscript! Isolated retinal artery occlusions have low risk of subsequent stroke, and they are more likely in situ events as opposed to embolic phenomena. https://t.co/akALMQr2CO @marcocolasurdo @JimSiegler @NguyenThanhMD @dgandhimd @umarylandneuro @UMDNeurosurgery

Is thrombolysis safe and effective for Moyamoya patients who present with acute ischemic stroke? Check out our new paper in NEUROLOGY! @Dheeraj_NIS @marcocolasurdo @mihir_khunte @AjayMalhotraRad @umarylandneuro @GtownNeurology

In this retrospective cohort study using the Nationwide Readmissions Database, Chen et al. explore the role of endovascular arterial embolization as an upfront treatment strategy for patients with severe epistaxis versus nasal packing alone and find benefit. #endovascular

Predictors and Outcomes of Excellent Recanalization Versus Successful Recanalization After Thrombectomy in Proximal and Distal Medium Vessel Occlusion Strokes: A Multinational Study https://t.co/DLA5qvtkD9 @StrokeAHA_ASA @SVINJournal @svinsociety

Is EVT better than MM for treating isolated PCA #strokes? 🤔Find out in our latest study published in the European Stroke Journal. Huge thanks to Dr. Benjamin Pulli, @vsyedavalli, @AdamDmytriw & @GuenegoAdrien for leading this important work! 🙌 https://t.co/JkTobjx0JZ

Thanks to all MAD-MT collaborators @MusmarBasel @NimerAdeeb @MAEssibayi @KareemNaamaniMD @JaneKhalife @SheriefGhozy @rwregen @JeremyHeitMDPHD @NMCancelliere @jbernstock1 @aymeric87 @Fie0815 @SunilAShethMD @AjitSPuri1 @marcocolasurdo @PiersKlein @AshkanMowla

We are launching a journal watch for new possibly practice-defining articles, with one-page summaries that capture key features of design and outcomes! For our first issue, we summarized the BASIS trial!

Stroke EVT for large core is assoc. w/ high rates of poor outcomes despite successful recanalization… can we predict this up front? Check out the simple SNAP score from the STAR registry published in Neurosurgery! @PeterKa80460001 @alex_spiotta https://t.co/odwu26pYKo

Should we offer stroke thrombectomy for large core patients with low perfusion mismatch? Check out our meta analysis of ANGEL-ASPECT and SELECT2 showing unclear benefit among patients with mismatch ratio <1.2 and volume <10cc. https://t.co/0k6mvBBYKz

@marcocolasurdo @Dheeraj_NIS @ChaturvediNeuro @GtownNeurology @umarylandneuro

Patient with CADASIL presents with an acute stroke within thrombolysis time window.. should we treat? Check out our research letter in Stroke! @Dheeraj_NIS @marcocolasurdo @mihir_khunte @AjayMalhotraRad @GtownNeurology https://t.co/87GfRP1OVL

Chiari I deformity, formerly Chiari I malformation, is a complex spectrum of pathophysiology spanning far beyond the classic “5 mm below the foramen magnum” framework. Consider the whole picture in Chiari I. https://t.co/x6CSvN7SIy @ellika_shehanaz

The Role of the Glymphatic System in the Formation of Brain Edema After Ischemic Stroke In this new #BloggingStroke post, Giuliana Pollaci discusses #Stroke article by Zhu et al. #AHAJournals https://t.co/xaIBIncbvt

Are we intervening on CVT too late? Check out our new paper on endovascular treatments for CVT! @mdneurorads @ThePaulSingh @AjayMalhotraRad @marcocolasurdo @mihir_khunte https://t.co/Wi7zKrUv86

Should we be administering bridging thrombolytics for elderly patients going for EVT? Maybe not! Check out our new paper on the topic: https://t.co/uWpWD4jCqW @mdneurorads @mihir_khunte @marcocolasurdo @AjayMalhotraRad

More stroke thrombectomy passes and longer procedure —> larger drop in hgb —> worse clinical outcomes! Should we be employing strategies to mitigate hgb decrease? Check out our paper: @ChaturvediNeuro @msphippsmd @marcocolasurdo @mdneurorads https://t.co/w1hQfMd7nI

While waiting for RCTs, here's data from a PSM analysis of MMA embo vs MMAe + sx. https://t.co/7X6zlxKDQN No difference: surgical rescue & radiologic failure. @HAlvinChenNeuro, @amdbaig, @SandraNarayanan, @BrianHoward_MD, @DrMichaelJLang, @DrMichaelLevitt, @PeterKa80460001